Shoppers Stop Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 15, 2025, 9:05 pm

Quick Insight

Shoppers Stop Ltd's current market cap of ₹5,759 Cr. appears steeply valued with a P/E ratio of 323, suggesting high earnings expectations. However, the company's ROE at 3.39% and ROCE at 7.96% indicate relatively weak profitability and efficiency. With a high debt level of ₹3,314 Cr. and a P/BV ratio of 18.77x, concerns arise over leverage and overvaluation. The company's OPM at 15% is decent, but with a low net profit of ₹11 Cr., sustainability may be a concern. While promoter holding is strong at 65.57%, institutional ownership is relatively low. Overall, investors should exercise caution due to the company's high valuation multiples, weak financial metrics, and significant debt burden.

Competitors of Shoppers Stop Ltd

All Competitor Stocks of Shoppers Stop Ltd

Quarterly Result

Last Updated: August 1, 2025, 12:00 pm

Below is a detailed analysis of the quarterly data for Shoppers Stop Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,161.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,064.00 Cr. (Mar 2025) to 1,161.00 Cr., marking an increase of 97.00 Cr..
• For Expenses, as of Jun 2025, the value is 990.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 894.00 Cr. (Mar 2025) to 990.00 Cr., marking an increase of 96.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 172.00 Cr.. The value appears strong and on an upward trend. It has increased from 170.00 Cr. (Mar 2025) to 172.00 Cr., marking an increase of 2.00 Cr..
• For OPM %, as of Jun 2025, the value is 15.00%. The value appears to be declining and may need further review. It has decreased from 16.00% (Mar 2025) to 15.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 10.00 Cr.. The value appears to be declining and may need further review. It has decreased from 20.00 Cr. (Mar 2025) to 10.00 Cr., marking a decrease of 10.00 Cr..
• For Interest, as of Jun 2025, the value is 73.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 70.00 Cr. (Mar 2025) to 73.00 Cr., marking an increase of 3.00 Cr..
• For Depreciation, as of Jun 2025, the value is 129.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 125.00 Cr. (Mar 2025) to 129.00 Cr., marking an increase of 4.00 Cr..
• For Profit before tax, as of Jun 2025, the value is -21.00 Cr.. The value appears to be declining and may need further review. It has decreased from -5.00 Cr. (Mar 2025) to -21.00 Cr., marking a decrease of 16.00 Cr..
• For Tax %, as of Jun 2025, the value is -25.00%. The value appears to be increasing, which may not be favorable. It has increased from -137.00% (Mar 2025) to -25.00%, marking an increase of 112.00%.
• For Net Profit, as of Jun 2025, the value is -16.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Mar 2025) to -16.00 Cr., marking a decrease of 18.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is -1.43. The value appears to be declining and may need further review. It has decreased from 0.18 (Mar 2025) to -1.43, marking a decrease of 1.61.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 3:02 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 2:22 pm

Below is a detailed analysis of the balance sheet data for Shoppers Stop Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 55.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 55.00 Cr..
• For Reserves, as of Mar 2025, the value is 266.00 Cr.. The value appears strong and on an upward trend. It has increased from 246.00 Cr. (Mar 2024) to 266.00 Cr., marking an increase of 20.00 Cr..
• For Borrowings, as of Mar 2025, the value is 3,314.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 2,785.00 Cr. (Mar 2024) to 3,314.00 Cr., marking an increase of 529.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 2,459.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,208.00 Cr. (Mar 2024) to 2,459.00 Cr., marking an increase of 251.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 6,095.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5,294.00 Cr. (Mar 2024) to 6,095.00 Cr., marking an increase of 801.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 2,971.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,582.00 Cr. (Mar 2024) to 2,971.00 Cr., marking an increase of 389.00 Cr..
• For CWIP, as of Mar 2025, the value is 13.00 Cr.. The value appears to be declining and may need further review. It has decreased from 21.00 Cr. (Mar 2024) to 13.00 Cr., marking a decrease of 8.00 Cr..
• For Investments, as of Mar 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Mar 2024) to 3.00 Cr., marking a decrease of 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 3,107.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,688.00 Cr. (Mar 2024) to 3,107.00 Cr., marking an increase of 419.00 Cr..
• For Total Assets, as of Mar 2025, the value is 6,095.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,294.00 Cr. (Mar 2024) to 6,095.00 Cr., marking an increase of 801.00 Cr..

However, the Borrowings (3,314.00 Cr.) are higher than the Reserves (266.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Shoppers Stop Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 0.99. This value is below the healthy minimum of 5. It has decreased from 7.03 (Mar 24) to 0.99, marking a decrease of 6.04.
• For Diluted EPS (Rs.), as of Mar 25, the value is 0.99. This value is below the healthy minimum of 5. It has decreased from 7.00 (Mar 24) to 0.99, marking a decrease of 6.01.
• For Cash EPS (Rs.), as of Mar 25, the value is 45.90. This value is within the healthy range. It has decreased from 46.73 (Mar 24) to 45.90, marking a decrease of 0.83.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.18. It has increased from 27.40 (Mar 24) to 29.18, marking an increase of 1.78.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.18. It has increased from 27.40 (Mar 24) to 29.18, marking an increase of 1.78.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 420.46. It has increased from 392.56 (Mar 24) to 420.46, marking an increase of 27.90.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 69.28. This value is within the healthy range. It has decreased from 70.28 (Mar 24) to 69.28, marking a decrease of 1.00.
• For PBIT / Share (Rs.), as of Mar 25, the value is 24.37. This value is within the healthy range. It has decreased from 30.58 (Mar 24) to 24.37, marking a decrease of 6.21.
• For PBT / Share (Rs.), as of Mar 25, the value is 0.63. This value is within the healthy range. It has decreased from 9.50 (Mar 24) to 0.63, marking a decrease of 8.87.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 2. It has decreased from 7.03 (Mar 24) to 0.98, marking a decrease of 6.05.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 2. It has decreased from 7.03 (Mar 24) to 0.98, marking a decrease of 6.05.
• For PBDIT Margin (%), as of Mar 25, the value is 16.47. This value is within the healthy range. It has decreased from 17.90 (Mar 24) to 16.47, marking a decrease of 1.43.
• For PBIT Margin (%), as of Mar 25, the value is 5.79. This value is below the healthy minimum of 10. It has decreased from 7.78 (Mar 24) to 5.79, marking a decrease of 1.99.
• For PBT Margin (%), as of Mar 25, the value is 0.15. This value is below the healthy minimum of 10. It has decreased from 2.41 (Mar 24) to 0.15, marking a decrease of 2.26.
• For Net Profit Margin (%), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 5. It has decreased from 1.78 (Mar 24) to 0.23, marking a decrease of 1.55.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 8. It has decreased from 1.78 (Mar 24) to 0.23, marking a decrease of 1.55.
• For Return on Networth / Equity (%), as of Mar 25, the value is 3.39. This value is below the healthy minimum of 15. It has decreased from 25.63 (Mar 24) to 3.39, marking a decrease of 22.24.
• For Return on Capital Employeed (%), as of Mar 25, the value is 8.69. This value is below the healthy minimum of 10. It has decreased from 12.84 (Mar 24) to 8.69, marking a decrease of 4.15.
• For Return On Assets (%), as of Mar 25, the value is 0.17. This value is below the healthy minimum of 5. It has decreased from 1.45 (Mar 24) to 0.17, marking a decrease of 1.28.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.29. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.29, marking an increase of 0.29.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.06. This value exceeds the healthy maximum of 1. It has increased from 0.57 (Mar 24) to 1.06, marking an increase of 0.49.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.81. It has decreased from 0.87 (Mar 24) to 0.81, marking a decrease of 0.06.
• For Current Ratio (X), as of Mar 25, the value is 0.85. This value is below the healthy minimum of 1.5. It has increased from 0.81 (Mar 24) to 0.85, marking an increase of 0.04.
• For Quick Ratio (X), as of Mar 25, the value is 0.17. This value is below the healthy minimum of 1. It has decreased from 0.18 (Mar 24) to 0.17, marking a decrease of 0.01.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.92. This value is below the healthy minimum of 3. It has decreased from 3.43 (Mar 24) to 2.92, marking a decrease of 0.51.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.04. This value is below the healthy minimum of 3. It has decreased from 1.37 (Mar 24) to 1.04, marking a decrease of 0.33.
• For Enterprise Value (Cr.), as of Mar 25, the value is 6,354.63. It has decreased from 8,425.19 (Mar 24) to 6,354.63, marking a decrease of 2,070.56.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.37. This value is within the healthy range. It has decreased from 1.95 (Mar 24) to 1.37, marking a decrease of 0.58.
• For EV / EBITDA (X), as of Mar 25, the value is 8.33. This value is within the healthy range. It has decreased from 10.90 (Mar 24) to 8.33, marking a decrease of 2.57.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.30. This value is within the healthy range. It has decreased from 1.92 (Mar 24) to 1.30, marking a decrease of 0.62.
• For Price / BV (X), as of Mar 25, the value is 18.77. This value exceeds the healthy maximum of 3. It has decreased from 27.44 (Mar 24) to 18.77, marking a decrease of 8.67.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.30. This value is within the healthy range. It has decreased from 1.92 (Mar 24) to 1.30, marking a decrease of 0.62.
• For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness